Amylyx Pharmaceuticals, Inc. (AMLX)
13.75
-0.35
(-2.48%)
USD |
NASDAQ |
Mar 06, 12:42
Amylyx Pharmaceuticals Cash from Investing (TTM) : 14.04M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Rapt Therapeutics, Inc. | -56.70M |
| Disc Medicine, Inc. | -394.30M |
| Cytokinetics, Inc. | 16.67M |
| Ionis Pharmaceuticals, Inc. | -277.78M |
| MediciNova, Inc. | -0.0029M |